Handling a High Relaxivity Contrast Material for Dynamic Breast MR Imaging Using Higher Thresholds for the Initial Enhancement

Investigative Radiology

Volumn 45, Issue 3, 2010, Pages 114-120

  Carbonaro, Luca A ^a   Verardi, Nicola ^a   Di Leo, Giovanni ^a   Sardanelli, Francesco ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Breast neoplasms; Contrast agents; Dynamic studies; Gadobenate dimeglumine; Magnetic resonance imaging

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADULT; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER CLASSIFICATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DYNAMICS; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALIDITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STANDARD; THREE DIMENSIONAL IMAGING; TUMOR CLASSIFICATION;

EID: 77249139763     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181cc2929     Document Type: Article

References (26)

1. ACR practice guideline for the performance of magnetic resonance imaging (MRI) of the breast [ACR web site]. October 1,2004. Available at:http:// www.acr.org/s-acr/bin.asp?CID = 549&DID = 17775&DOC = FILE.PDF. Accessed July 2,2009.
2. Pediconi F, Catalano C, Roselli A, et al. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with X-ray mammography and whole-breast ultrasound. Invest Radiol. 2009;44:412-421.
3. Heywang-Kobrunner SH, Beck R Contrast-Enhanced MRI of the Breast. 2nd ed. Berlin, Germany: Springer-Verlag; 1995.
4. Kuhl CK. The current status of breast MR imaging. Part I: choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology. 2007;244:356-378.
5. Kuhl CK, Schild HH, Morakkabati N. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. Radiology. 2005;236:789-800.
6. Pinker K, Grabner G, Bogner W, et al. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results. Invest Radiol. 2009;44:553-558.
7. American College of Radiology (ACR). Breast Imaging Reporting and Data System (BI-RADS) Atlas. 4th ed. Reston, VA: American College of Radiology;2003.
8. Nunes LW, Schnall MD, Orel SG. Update of breast MR imaging architectural interpretation model. Radiology. 2001;219:484-494.
9. Schnall MD, Blume J, Bluemke DA, et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology. 2006; 238:42-53.
10. Knopp MV, Bourne MW, Sardanelli F, et al. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. Am J Roentgenol. 2003;181:663-676.
11. Pediconi F, Catalano C, Padula S, et al. Contrast-enhanced MR mammography: improved lesion detection and differentiation with gadobenate dimeglumine. Am J Roentgenol. 2008;191:1339-1346.
12. Sardanelli F, Iozzelli A, Fausto A, et al. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity. Radiology. 2005;235:791-797.
13. Sardanelli F, Fausto A, Esseridou A, et al. Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance. Invest Radiol. 2008;43:236-242.
14. Sardanelli F, Giuseppetti GM, Canavese G, et al. Indications for breast magnetic resonance imaging. Consensus document "Attualita in senologia," Florence 2007 [in Italian]. Radiol Med. 2008;113:1085-1095.
15. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology. 1999;213:881-888.
16. Baum F, Fischer U, Vosshenrich R, et al. Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol. 2002;12:1087-1092.
17. Tavassoli FA, Devilee P. World Health Organization tumors of the breast and female genital organs. In: Kleihues P, Sobin L, eds. World Health Organization Classification of Tumors. 5th ed. Lyon, FR: IARC Press; 2003:35-36.
18. Ciatto S, Houssami N, Ambrogetti D, et al. Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies. Breast Cancer Res Treat. 2007;101:291-297.
19. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol. 1997;32:780-796.
20. de Haen C, Cabrini M, Akhnana L, et al. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance) pharmaceutical formulation and physico-chemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr. 1999;23:S161-S168. (Pubitemid 30027605)
21. Pintaske J, Martirosian P, Graf H, et al. Relaxivity of Gadopentetate Dimeglumine (Magnevist), Gadobutrol (Gadovist), and Gadobenate Dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla [Erratum in: Invest Radiol. 2006;41:859]. Invest Radiol. 2006;41:213-221. (Pubitemid 44406181)
22. Giesel FL, von Tengg-Kobligk H, Wilkinson ID, et al. Influence of human serum albumin on longitudinal and transverse relaxation rates (r1 and r2) of magnetic resonance contrast agents. Invest Radiol. 2006;41:222-228.
23. Peters NH, Borel Rinkes IH, Zuithoff NP, et al. Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology. 2008;246:116-124.
24. Pediconi F, Catalano C, Occhiato R, et al. Breast lesion detection and characterization at contrast-enhanced MR mammography: gadobenate dimeglumine versus gadopentetate dimeglumine. Radiology. 2005;237:45-56.
25. Saslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography [Erratum in: CA Cancer J Clin. 2007;57:185]. CA Cancer J Clin. 2007;57:75-89. (Pubitemid 46535708)
26. Sardanelli F, Podo F, D'Agnolo G, et al. Multicenter comparative multimo-dality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology. 2007;242:698-715.